These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 25362113)

  • 1. Neuroprotective effects of angiotensin receptor blockers.
    Villapol S; Saavedra JM
    Am J Hypertens; 2015 Mar; 28(3):289-99. PubMed ID: 25362113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders.
    Saavedra JM
    Clin Sci (Lond); 2012 Nov; 123(10):567-90. PubMed ID: 22827472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence to Consider Angiotensin II Receptor Blockers for the Treatment of Early Alzheimer's Disease.
    Saavedra JM
    Cell Mol Neurobiol; 2016 Mar; 36(2):259-79. PubMed ID: 26993513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial effects of Angiotensin II receptor blockers in brain disorders.
    Saavedra JM
    Pharmacol Res; 2017 Nov; 125(Pt A):91-103. PubMed ID: 28711402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurorestoration after traumatic brain injury through angiotensin II receptor blockage.
    Villapol S; Balarezo MG; Affram K; Saavedra JM; Symes AJ
    Brain; 2015 Nov; 138(Pt 11):3299-315. PubMed ID: 26115674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do angiotensin receptor blockers prevent Alzheimer's disease?
    Hajjar I; Rodgers K
    Curr Opin Cardiol; 2013 Jul; 28(4):417-25. PubMed ID: 23703253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II AT(1) receptor blockers ameliorate inflammatory stress: a beneficial effect for the treatment of brain disorders.
    Saavedra JM
    Cell Mol Neurobiol; 2012 Jul; 32(5):667-81. PubMed ID: 21938488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin receptor blockers and cerebral protection in stroke.
    Thöne-Reineke C; Steckelings UM; Unger T
    J Hypertens Suppl; 2006 Mar; 24(1):S115-21. PubMed ID: 16601564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of angiotensin receptor blockers in cerebrovascular disorders and dementia: bonus in addition to the antihypertensive effect].
    Kovács T
    Ideggyogy Sz; 2014 May; 67(5-6):149-68. PubMed ID: 25087375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of chronic treatment with angiotensin type 1 receptor antagonists on striatal dopamine levels in normal rats and in a rat model of Parkinson's disease treated with L-DOPA.
    Dominguez-Meijide A; Villar-Cheda B; Garrido-Gil P; Sierrra-Paredes G; Guerra MJ; Labandeira-Garcia JL
    Neuropharmacology; 2014 Jan; 76 Pt A():156-68. PubMed ID: 23973568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: Therapeutic implications.
    Saavedra JM; Sánchez-Lemus E; Benicky J
    Psychoneuroendocrinology; 2011 Jan; 36(1):1-18. PubMed ID: 21035950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of angiotensin receptor blockers in reducing the risk of cardiovascular disease.
    Abramov D; Carson PE
    J Renin Angiotensin Aldosterone Syst; 2012 Sep; 13(3):317-27. PubMed ID: 22610916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II type 1 receptor blockade: high hopes sent back to reality?
    Grothusen A; Divchev D; Luchtefeld M; Schieffer B
    Minerva Cardioangiol; 2009 Dec; 57(6):773-85. PubMed ID: 19942847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebroprotective effects of RAS inhibitors: Beyond their cardio-renal actions.
    Kalra J; Prakash A; Kumar P; Majeed AB
    J Renin Angiotensin Aldosterone Syst; 2015 Sep; 16(3):459-68. PubMed ID: 25944853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renin-Angiotensin System and Alzheimer's Disease Pathophysiology: From the Potential Interactions to Therapeutic Perspectives.
    Ribeiro VT; de Souza LC; Simões E Silva AC
    Protein Pept Lett; 2020; 27(6):484-511. PubMed ID: 31886744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond blood pressure: evidence for cardiovascular, cerebrovascular, and renal protective effects of renin-angiotensin system blockers.
    Verdecchia P; Gentile G; Angeli F; Reboldi G
    Ther Adv Cardiovasc Dis; 2012 Apr; 6(2):81-91. PubMed ID: 22528743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathophysiological and clinical implications of AT(1) and AT(2) angiotensin II receptors in metabolic disorders: hypercholesterolaemia and diabetes].
    Strawn WB
    Drugs; 2002; 62 Spec No 1():31-41. PubMed ID: 12036387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme inhibitors (ACEIs), not angiotensin receptor blockers (ARBs), are preferred and effective mode of therapy in high cardiovascular risk patients.
    Vijan SG
    J Indian Med Assoc; 2009 Mar; 107(3):178-82. PubMed ID: 19810392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
    Abassi Z; Armaly Z; Nakhoul F; Hoffman A
    Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.